Category Archives: MS Treatment

DUBLIN (AP) Irish drug maker Elan Corp. announced Monday it will pay shareholders a recurring special dividend linked to the sales of the multiple sclerosis treatment Tysabri. Analysts said the offer, contingent on Elan's pending sale of its Tysabri rights to partner Biogen Idec Inc., was designed to deter shareholders from considering a takeover bid by Royal Pharma. Elan said it planned to pay shareholders 20 percent of its Tysabri royalties received from Biogen twice annually beginning in the fourth quarter this year. "This dividend structure gives shareholders the right to enjoy unlimited participation in the upside from the Tysabri sales increase which we anticipate for the future," Elan said in a statement. Elan and Biogen jointly developed Tysabri and have split earnings since the drug's troubled launch in the U.S. market in 2004. They soon withdrew Tysabri from sale after three MS sufferers using the drug contracted PML, a rare brain-inflammation disease that is often fatal. But since its return to sale in 2006 under restricted conditions Tysabri has gradually gained market traction because, despite its PML risks, it is considered most effective at reducing the frequency and severity of sudden immobilization or partial paralysis experienced by MS patients. … Continue reading →

BOSTON--(BUSINESS WIRE)-- Today we announce the launch of Orion Bionetworks, a multi-institution cooperative non-profit alliance that is unlocking the power of shared data and predictive modeling to help transform our understanding of diseases such as multiple sclerosis (MS) and accelerate the search for cures. Alliance partners include leading organizations in patient care, computational modeling, translational research, and patient advocacy: Accelerated Cure Project for Multiple Sclerosis, the Institute for Neurosciences at Brigham and Womens Hospital, GNS Healthcare, MetaCell, and PatientsLikeMe. Janssen Research & Development, LLC, a New Jersey-based pharmaceutical company, has provided a $5.4 million scientific sponsorship as part of its Healthy Minds program for the initial phase of this effort. Orion Bionetworks has been established as a program of the Marin Community Foundation. Its President & CEO, Thomas Peters, Ph.D., hailed the formation of the new alliance. We are enormously proud to welcome Orion Bionetworks within the Foundation, said Peters. We are confident that this blend of expertise and creativity will lead to significant scientific success. Key supporting partners include One Mind for Research, Morrison & Foerster, Recombinant Data, and Weber Shandwick. A Unique Cooperative Alliance Through Orion Bionetworks, alliance partners contribute to a communal body of knowledge in the … Continue reading →

WALTHAM, Mass.--(BUSINESS WIRE)-- Accelerated Cure Project for Multiple Sclerosis (ACP-MS) today announced the launch of Orion Bionetworks, a multi-institution cooperative alliance that is unlocking the power of shared data and predictive modeling to help transform our understanding of diseases such as multiple sclerosis (MS) and accelerate the search for cures. Orion Bionetworks is a program of the Marin Community Fund, a nonprofit 501(c)(3) corporation, and is funded by Janssen Research & Development, LLC, a New Jersey-based pharmaceutical company, which has provided a $5.4 million scientific sponsorship as part of its Healthy Minds program for the first phase of this effort. Initially, this cooperative alliance will focus on integrating clinical, biomarker and imaging data with rich real-world patient data from existing, independent databases of over 7,000 people with MS into a causal computational disease model. We are delighted to collaborate with such a dynamic group of innovators to launch Orion Bionetworks, said Robert McBurney, Chief Executive Officer of ACP-MS. Orion is demonstrating that a predictive disease modeling alliance that uses real-world patient data can have an unprecedented ability to drive toward better treatments and, ultimately, cures for multiple sclerosis and other devastating brain disorders. Our involvement in the alliance is a … Continue reading →

Low Dose Naltrexone (LDN) costs 300 a year privately Drug is not available on the NHS as it has not been trialled to combat MS By Anastasia Parks PUBLISHED: 17:00 EST, 2 March 2013 | UPDATED: 17:01 EST, 2 March 2013 In July 2009, my husband took me to Henley Royal Regatta, the scene of many of his youthful triumphs. We enjoyed a long, hot sunny day sipping Pimms. It was bliss, not least because since being diagnosed with multiple sclerosis the summer before, I had become increasingly anxious about outings to beaches or markets, or even parties and weddings. For years, Id been suffering increasing tingling and numbness in my limbs that became impossible to ignore. A clicking hip while pregnant with my youngest son now seven was followed by weakness in my leg, numbness in both feet, night cramps and weak bladder control. After myriad appointments, tests and MRI scans, I received my diagnosis: primary progressive multiple sclerosis. Patient choice: Anastasia Parks has to buy Low Dose Naltrexone privately This is an uncommon form of the neurological condition which progresses inexorably. But like all variations of MS, in which the immune system turns inward and attacks the nervous … Continue reading →

Newswise SAN DIEGO The American Academy of Neurology and the National Multiple Sclerosis Society are awarding the 2013 John Dystel Prize for MS Research to George C. Ebers, MD, a leading researcher with the University of Oxford and Oxford University Hospitals Trust in Oxford, United Kingdom. Ebers will receive the award at the Academys 65th Annual Meeting in San Diego, March 16-23, 2013. The Annual Meeting is the worlds largest gathering of neurologists with more than 10,000 attendees and more than 2,300 scientific presentations on the latest research advancements in brain disease. The John Dystel Prize recognizes a significant contribution to research in the understanding, treatment or prevention of multiple sclerosis (MS). Ebers research has focused on genetic and environmental influences on MS risks. We have found that MS risk factors previously considered to be genetic can be changed based on environment, strongly implicating gene-environment interaction. Our studies highlight how climate and diet relate to factors leading to MS, which can be views as a largely preventable disease. Vitamin D exposure appears to be the main factor determining geographical risk said Ebers. This award is made possible through a special contribution from the John Dystel Multiple Sclerosis Research Fund at … Continue reading →

WARWICK, RI--(Marketwire - Mar 1, 2013) - Today, the National Multiple Sclerosis Society announced its partnership with 63 Edible Arrangements stores of Rhode Island, Massachusetts, and New Hampshire for its second annual MS awareness campaign to raise funds to help people with MS and to support MS research. Last year, these Edible Arrangements locations donated $10,000 to this cause. Edible Arrangements stores throughout Rhode Island, Massachusetts, and New Hampshire will donate five dollars from every Orange Blossom arrangement purchased during March, National MS Society's MS Awareness Month.Orange is the official color of the Society. "This fundraiser began two years ago with Edible Arrangements Boston-Manchester Co-op and recently expanded to include all of the Rhode Island locations," said Ted Kostisin, president of the Edible Arrangements Rhode Island Co-op. "The Rhode Island stores are eager to contribute to the cause and demonstrate our support for our neighboring co-op and for the Rhode Island Chapter of the National MS Society." "We value Edible Arrangements continuing generosity and we look forward to using those funds to help local individuals and families who are affected by MS, at the same time that we fund cutting-edge research around the country," said Kathy Mechnig, president of the … Continue reading →

WALTHAM, MA--(Marketwire - Mar 1, 2013) - Today, the National Multiple Sclerosis Society announced its partnership with 63 Edible Arrangements stores of Massachusetts, New Hampshire, and Rhode Island for its second annual MS awareness campaign to raise funds to help people with MS and to support MS research. Last year, these Edible Arrangements locations donated $10,000 to this cause. Edible Arrangements stores throughout Massachusetts, New Hampshire, and Rhode Island will donate five dollars from every Orange Blossom arrangement purchased during March, National MS Society's MS Awareness Month.Orange is the official color of the Society. "Last year, we were able to present the National MS Society a check for $10,000," said Nick D'Alleva, the Edible Arrangements franchisee whose passion for MS fundraising and awareness inspired the now annual fundraiser. "It's our second year, more people know about it and we have even more stores involved. To learn more about our fundraising efforts, join us March 2nd at the MS Climb to the Top event at the John Hancock Tower in Boston." "Thanks to Nick and the entire Edible Arrangements team, the National MS Society is able to help local individuals and families who are affected by MS, at the same time … Continue reading →

Seattle cosmetic surgeon Dr. Alex Sobel of Anderson Sobel Cosmetic Surgery is pleased to welcome Desiree Cannon to the staff as the newest esthetician. Bellevue, WA (PRWEB) February 26, 2013 As an experienced esthetician, Ms. Cannon has years of experience specializing in skin care treatments. Ms. Cannon has been working for the past decade at some of the top clinics in Washington. She is aware of all the latest technologies and advancements in the industry. Her background makes her one of the most sought-after estheticians in the region. Her eye for attention to detail and her dedication to patients makes her one of the best in the skin care field. Ms. Cannon has offered laser hair removal, microdermabrasion, photo facials, and other major skin care treatments to countless satisfied patients. "Desiree is among the most accomplished medical estheticians in Seattle. Her talent, experience and knowledge shine as she practices her unique and evidence-based approach to esthetic skin care. Having worked closely with Desiree, I can attest to her exceptional technique with chemical peels, lasers and skin care. Please afford her the opportunity to impress you as much as she has I," said Dr. Alex Sobel. For skin care, Seattle treatment … Continue reading →

Chances are, you know someone who suffers from Multiple Sclerosis. But MS affects each person differently, so understanding the disease is the key to treatment. March is the perfect month to gain the knowledge,as it's MS awareness month. "It impacts every minute of every day," says Susan Terry who was diagnosed with MS four years ago. "My vision just totally went double one day," says Terry. But for almost ten years before that, she was told by doctors she had Lupus. "You lived a good eight to ten years of life thinking I had Lupus and now all of the sudden I have a whole different thing to deal with," explains Terry. Terry's symptoms include being fatigue, a loss of balance, and worsening eye sight. "That's one of the problems with MS, it's frequently diagnosed wrong or it takes long to get the diagnoses because the symptoms can vary so much from person to person and can also mimic other diseases," explains Terry. Now Terry uses a cane to get around easier. "I wasn't quite sure about it, but when she [doctor] gave it to me and I started using it, it's great. It gives you a little extra security," … Continue reading →

The mum who tried to stop her son from having radiotherapy to fight a brain tumour said her boy is more at risk now hes being treated. Sally Roberts, 37, went on the run with Neon, seven, last year before a court ordered him to have the treatment. Although the youngster has a survival rate of up to 82% now, Ms Roberts said she was upset by the decision to press ahead. Asked for her view on the legal battle, she told BBC Radio 5 Live's Victoria Derbyshire: "I stand by that. I'm upset that they moved forward in the way they have. "I'm having to face the side-effects from the radiation and the chemotherapy, which is devastating." Ms Roberts, a New Zealander living in Brighton, East Sussex, said "weak and fragile" Neon was "more in jeopardy now". She said: He is not able to go to school and his immune system is very much down. He is suffering from chronic fatigue, constipation, nausea, loss of appetite, weight loss, hair loss, reduction in saliva, damage to the salivary glands and poor short-term memory. But, despite the side-effects, Ms Roberts said she has been told the success rate from having the … Continue reading →